CJC-1295 DAC 2 mg (2000 mcg)/vial – US Stock

CJC-1295 DAC 2 mg (2000 mcg)/vial from Hilma Biocare is an injectable peptide hormone containing CJC-1295 DAC. It is supplied as a powder in a single vial containing 2 mg (2000 mcg) of the stated active compound.

Product Overview

CJC-1295 DAC is a modified peptide associated with the stimulation of growth hormone release. The supplied product description characterizes the DAC formulation as long-acting and describes it as producing a more sustained pattern of growth hormone release compared with shorter-acting growth hormone-releasing peptides.

The product specifications identify an active half-life of approximately 6–8 hours. CJC-1295 DAC is classified as a peptide hormone in an injectable powder format, with water retention listed as present and aromatization listed as absent.

Active Ingredient

The active ingredient is CJC-1295 DAC, a peptide hormone compound.

Form and Strength

The product is supplied as an injectable powder containing 2 mg (2000 mcg) per vial.

Product Characteristics

According to the supplied specifications, CJC-1295 DAC has the following characteristics:

• Peptide hormone
• Injectable powder formulation
• 2 mg (2000 mcg) per vial
• Approximately 6–8-hour active half-life
• Single-vial presentation
• Water retention listed as present
• Aromatization listed as absent

Product Specifications

Product Characteristics

CJC-1295 DAC is described in the supplied information as a long-acting peptide associated with growth hormone release. The source material distinguishes the DAC formulation from shorter-acting GHRP compounds by describing a more sustained release profile rather than short-term spikes.

The supplied description also discusses CJC-1295 DAC in relation to muscle development, body composition, collagen synthesis, connective tissue, and general well-being. These statements are source-based and should not be interpreted as guaranteed therapeutic, athletic, cosmetic, or performance outcomes.

Reported Side Effects

The supplied product information identifies excessive water retention and weakness as potential side effects associated with CJC-1295 DAC.

Because CJC-1295 DAC is a biologically active peptide that affects growth hormone signaling, potential risks, contraindications, and interactions should be reviewed with an appropriately qualified healthcare professional.

Important Information

CJC-1295 DAC is a pharmacologically active peptide hormone and is not presented as a general nutritional supplement. The information on this page is provided for product identification and factual specification purposes only and does not constitute personalized medical advice.

No dosage recommendations, injection instructions, reconstitution procedures, treatment protocols, or stacking regimens are provided. The supplied source mentions combining CJC-1295 DAC with other peptides, anabolic-androgenic steroids, or HGH; these combinations are not presented here as recommendations.

About Hilma Biocare USA

CJC-1295 DAC 2 mg (2000 mcg)/vial is part of the Hilma Biocare product range. The product contains a labeled 2 mg (2000 mcg) quantity of CJC-1295 DAC and is supplied as one injectable powder vial, listed as US Stock.